Eur Rev Med Pharmacol Sci 2020; 24 (23): 11985-11985
DOI: 10.26355/eurrev_202012_23949

SOCS3 overexpression enhances ADM resistance in bladder cancer T24 cells

M.-Z. Li, D.-H. Lai, H.-B. Zhao, Z. Chen, Q.-X. Huang, J. Situ

Department of Urology, The Third Affiliated Hospital Sun Yat-Sen University, Guangzhou, Guangdong, China.


The article “SOCS3 overexpression enhances ADM resistance in bladder cancer T24 cells, by M.-Z. Li, D.-H. Lai, H.-B. Zhao, Z. Chen, Q.-X. Huang, J. Situ, published in Eur Rev Med Pharmacol Sci 2017; 21 (13): 3005-3011–PMID: 28742207” has been withdrawn due to misunderstandings among some authors (Dr. Dehui Lai and Dr. Haibo Zhao) concerning the submission of the article.

The Publisher apologizes for any inconvenience this may cause.

SOCS3 overexpression enhances ADM resistance in bladder cancer T24 cells

Free PDF Download

To cite this article

M.-Z. Li, D.-H. Lai, H.-B. Zhao, Z. Chen, Q.-X. Huang, J. Situ
SOCS3 overexpression enhances ADM resistance in bladder cancer T24 cells

Eur Rev Med Pharmacol Sci
Year: 2020
Vol. 24 - N. 23
Pages: 11985-11985
DOI: 10.26355/eurrev_202012_23949